Lightdeck Diagnostics News Today

VANCOUVER, BC, Feb. 6, 2023 /PRNewswire/ -- The Veterinary Diagnostics Market size reached USD 6.63 Billion in 2021 and is expected to register a CAGR of 11.2%

/PRNewswire/ -- The Veterinary Diagnostics Market size reached USD 6.63 Billion in 2021 and is expected to register a CAGR of 11.2% during the forecast period,...

Morgan Stanley expects annual growth of 8% in the pet industry by 2030, noting that there has been an addition of nearly 5 million pets in the United States as compared to 2019, mainly due to the COVID...

/PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty...

Meet Denver's young leaders—CEOs, Founders and Senior VPs—shaping the modern world of business in our Centennial state.

/PRNewswire/ -- LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today announced it has...

The firm will develop a rapid test for its LightDeck analyzer to detect C-reactive proteins, inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers.

The company has now raised approximately $45.75 million in venture-capital funds, according to previous SEC disclosures. It’s unclear for what those funds will be used. The company did not respond to a request for comment Thursday. BOULDER — LightDeck Diagnostics, a firm building equipment for rapid diagnosis of COVID-19 and other illnesses, has raised an additional $9.9 million.  The Boulder company raised those funds by selling a combination of equity and future warrants, according to a ...